I
Immunera develops machine‑learning‑driven blood tests that analyze gene sequencing data to profile immune activity. The tests aim to help clinicians diagnose and monitor autoimmune conditions such as rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis by providing detailed immunological insights. Immunera monetizes its platform by selling these diagnostic assays directly to healthcare providers and laboratories for clinical use.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Immunera develops blood tests utilizing machine learning and gene sequencing to analyze biological data related to immune responses. These diagnostic tools are designed to assist clinicians in making more informed treatment decisions for patients suffering from autoimmune diseases. The company focuses on translating complex immunome information into actionable clinical insights for conditions like rheumatoid arthritis and multiple sclerosis.